KK
KRYS icon

KLP Kapitalforvaltning’s Krystal Biotech KRYS Stock Holding History

KLP Kapitalforvaltning’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Hold
4,800
– – 0.01% 837
2026
Q1 		$1.24M Buy
4,800
+100
+2% +$26.6K ﹤0.01% 929
2025
Q4 		$1.16M Hold
4,700
– – ﹤0.01% 961
2025
Q3 		$830K Buy
4,700
+400
+9% +$59.9K ﹤0.01% 1135
2025
Q2 		$591K Hold
4,300
– – ﹤0.01% 1275
2025
Q1 		$775K Hold
4,300
– – ﹤0.01% 1067
2024
Q4 		$674K Buy
+4,300
New +$763K ﹤0.01% 1191

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

KLP Kapitalforvaltning's KRYS Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Krystal Biotech (KRYS) position steady in Q2 2026 at 4,800 shares worth $1.78M. The position accounts for 0.01% of the portfolio, ranked #837.

KLP Kapitalforvaltning first reported a position in KRYS in Q4 2024 and has held it in 7 quarters since. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • KLP Kapitalforvaltning held 4,800 shares of Krystal Biotech worth $1.78M as of Q2 2026.
  • KLP Kapitalforvaltning left its Krystal Biotech share count unchanged in Q2 2026.
  • Krystal Biotech made up 0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #837 holding.
  • KLP Kapitalforvaltning first reported a position in Krystal Biotech in Q4 2024 and has held it in 7 quarters since.
  • 424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.